Mason Street Advisors’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,629
| Closed | -$253K | – | 1395 |
|
|
2020
Q4 | $253K | Sell |
12,629
-79
| -0.6% | -$1.55K | ﹤0.01% | 1368 |
|
|
2020
Q3 | $218K | Buy |
12,708
+18
| +0.1% | +$340 | ﹤0.01% | 1324 |
|
|
2020
Q2 | $277K | Buy |
12,690
+816
| +7% | +$18.7K | 0.01% | 1260 |
|
|
2020
Q1 | $275K | Hold |
11,874
| – | – | 0.01% | 1183 |
|
|
2019
Q4 | $392K | Buy |
11,874
+306
| +3% | +$9.81K | 0.01% | 1211 |
|
|
2019
Q3 | $368K | Buy |
11,568
+217
| +2% | +$6.33K | 0.01% | 1191 |
|
|
2019
Q2 | $292K | Buy |
11,351
+503
| +5% | +$12.8K | 0.01% | 1261 |
|
|
2019
Q1 | $275K | Buy |
10,848
+357
| +3% | +$10.7K | 0.01% | 1326 |
|
|
2018
Q4 | $357K | Buy |
10,491
+583
| +6% | +$19K | 0.01% | 1153 |
|
|
2018
Q3 | $353K | Buy |
9,908
+243
| +3% | +$8.58K | 0.01% | 1218 |
|
|
2018
Q2 | $333K | Buy |
9,665
+466
| +5% | +$16.3K | 0.01% | 1223 |
|
|
2018
Q1 | $310K | Buy |
9,199
+1,096
| +14% | +$34.7K | 0.01% | 1204 |
|
|
2017
Q4 | $310K | Sell |
8,103
-293
| -3% | -$11.7K | 0.01% | 1194 |
|
|
2017
Q3 | $315K | Buy |
8,396
+236
| +3% | +$8.33K | 0.01% | 1176 |
|
|
2017
Q2 | $304K | Buy |
8,160
+475
| +6% | +$17.2K | 0.01% | 1154 |
|
|
2017
Q1 | $302K | Buy |
7,685
+493
| +7% | +$18.5K | 0.01% | 1133 |
|
|
2016
Q4 | $250K | Buy |
7,192
+409
| +6% | +$16.1K | 0.01% | 1174 |
|
|
2016
Q3 | $267K | Buy |
6,783
+309
| +5% | +$12.3K | 0.01% | 1111 |
|
|
2016
Q2 | $245K | Buy |
6,474
+580
| +10% | +$19.4K | 0.01% | 1106 |
|
|
2016
Q1 | $227K | Buy |
5,894
+572
| +11% | +$21.3K | 0.01% | 1098 |
|
|
2015
Q4 | $256K | Buy |
5,322
+448
| +9% | +$20.7K | 0.01% | 1034 |
|
|
2015
Q3 | $192K | Buy |
4,874
+320
| +7% | +$13.6K | 0.01% | 1090 |
|
|
2015
Q2 | $194K | Buy |
4,554
+315
| +7% | +$12.6K | 0.01% | 1093 |
|
|
2015
Q1 | $167K | Buy |
4,239
+52
| +1% | +$1.92K | 0.01% | 1138 |
|
|
2014
Q4 | $151K | Buy |
4,187
+155
| +4% | +$5.21K | ﹤0.01% | 1581 |
|
|
2014
Q3 | $119K | Buy |
4,032
+396
| +11% | +$10.9K | ﹤0.01% | 1626 |
|
|
2014
Q2 | $91K | Buy |
3,636
+233
| +7% | +$5.76K | ﹤0.01% | 1692 |
|
|
2014
Q1 | $88K | Sell |
3,403
-1,030
| -23% | -$26K | ﹤0.01% | 1678 |
|
|
2013
Q4 | $100K | Buy |
4,433
+365
| +9% | +$7.05K | ﹤0.01% | 1700 |
|
|
2013
Q3 | $58K | Sell |
4,068
-142
| -3% | -$1.9K | ﹤0.01% | 1660 |
|
|
2013
Q2 | $57K | Buy |
+4,210
| New | +$57.4K | ﹤0.01% | 1586 |
|
Other funds holding NTUS
N
Mason Street Advisors's NTUS Position: Q1 2021 in Review
Mason Street Advisors sold out of Natus Medical Inc (NTUS) in Q1 2021, closing a stake of 12,629 shares — an estimated $253K sold.
Mason Street Advisors first reported a position in NTUS in Q2 2013 and held it in 31 quarters. The position peaked at $392K in Q4 2019. 156 funds tracked by Wall St. Rank hold NTUS as of Q1 2021.
- Mason Street Advisors reported no remaining Natus Medical Inc position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 12,629 Natus Medical Inc shares in Q1 2021, an estimated $253K.
- Mason Street Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Natus Medical Inc position peaked at $392K in Q4 2019.
- 156 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.